Utilization and short-term outcomes of percutaneous left atrial appendage occlusion in patients with cancer

BACKGROUND: Percutaneous left atrial appendage occlusion (LAAO) has been rapidly evolving since FDA’s approval in 2015 and has become more of a same-day-discharge procedure. Cancer patient with atrial fibrillation/flutter (AF) population can benefit from the procedure but the in-hospital outcomes an...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yaqi, Yang, Zhuoran, Almani, Muhammad U., Soon-Shiong, Raquel, Liu, Bolun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625234/
https://www.ncbi.nlm.nih.gov/pubmed/37924143
http://dx.doi.org/10.1186/s40959-023-00192-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625234/
https://www.ncbi.nlm.nih.gov/pubmed/37924143
http://dx.doi.org/10.1186/s40959-023-00192-z

Ejemplares similares